Acquiring an established SLP clinic offers immediate cash flow, trained clinicians, and referral pipelines — but starting fresh gives you control over culture, systems, and specialization. Here's how to decide which path is right for you.
For licensed SLPs, healthcare entrepreneurs, and PE-backed therapy platforms, the decision to acquire an existing speech therapy practice versus building one from the ground up is one of the most consequential choices in the journey toward ownership. Acquiring a practice means paying a premium — typically 3.5x to 6x EBITDA — in exchange for an immediate revenue base, credentialed clinician staff, established payer contracts, and a warm referral network from schools, pediatricians, and ENT specialists that can take years to cultivate organically. Building from scratch costs less upfront and offers full design freedom over clinical specialization, technology stack, and team culture, but requires 18–36 months to reach meaningful revenue and exposes you to the brutal realities of the SLP workforce shortage and payer credentialing timelines. The right answer depends heavily on your clinical background, capital access, risk tolerance, and whether you're entering a market with an existing demand gap or a competitive landscape already shaped by established practices.
Find Speech Therapy Practice Businesses to AcquireAcquiring an established speech therapy practice gives you day-one access to a functioning revenue engine — credentialed SLPs, active patient caseloads, insurance contracts, and referral relationships that took the founder a decade or more to build. In a field defined by trust, reputation, and clinical continuity, buying an existing practice dramatically compresses your path to profitability and reduces the risk of the long ramp-up period that kills most de novo healthcare ventures.
Licensed SLPs with entrepreneurial ambition backed by SBA financing, PE-backed therapy roll-up platforms seeking geographic expansion, or experienced healthcare operators who want a proven cash-flowing asset rather than a startup risk profile.
Starting a speech therapy practice from scratch is the path of maximum control and minimum acquisition premium — but it demands patience, capital reserves, and a clear plan to solve the two hardest problems in the industry: hiring licensed SLPs in a tight labor market and getting in front of the right referral sources before your runway runs out. For clinicians with a differentiated specialty focus, a built-in referral relationship, or access to an underserved geographic market, building can be a compelling path to long-term equity value.
Licensed SLPs with a strong existing referral relationship or community presence, entrepreneurs entering a demonstrably underserved geographic market with a waitlist demand signal, or specialists launching a focused niche practice where no suitable acquisition target exists.
For most buyers — particularly those with access to SBA financing, a healthcare management background, or a platform strategy — acquiring an established speech therapy practice is the superior path. The SLP workforce shortage, long payer credentialing timelines, and the relationship-driven nature of referral development make organic growth painfully slow and capital-intensive. Paying 4x–6x EBITDA for a practice with 3+ employed SLPs, diversified payer mix, and durable school or physician referral contracts is a rational premium for a business that is already generating $200K–$600K in annual EBITDA with a defensible moat. Build only if you have a specific clinical niche, a pre-existing referral base, or are entering a market where no suitable acquisition targets exist — and only if you have 24+ months of operating capital to survive the credentialing and ramp-up gauntlet.
Do you have access to $700K–$2M in acquisition capital or SBA financing capacity, or are you limited to $200K or less in startup capital?
Is there a quality acquisition target available in your target market with 3+ employed SLPs, clean financials, and referral sources not concentrated in the selling owner?
Do you already have established referral relationships with a pediatric practice, school district, or hospital system that could anchor a de novo practice's early caseload?
How long can your personal finances sustain 18–24 months of breakeven or below-breakeven operations while building payer contracts and SLP staff from scratch?
Are you acquiring primarily for cash flow and an existing EBITDA base, or are you building toward a specific clinical identity or specialization that doesn't exist in available acquisition targets?
Browse Speech Therapy Practice Businesses For Sale
Skip the build phase — acquire existing customers, revenue, and cash flow from day one.
Most speech therapy practices in the lower middle market sell for 3.5x to 6x EBITDA, which translates to roughly $700K to $3M for practices generating $1M–$5M in annual revenue with 15–30% EBITDA margins. Practices with multiple employed SLPs, diversified payer mix, school district contracts, and minimal owner clinical involvement command the higher end of that range. Practices where the owner handles the majority of billable hours or carries heavy Medicaid concentration typically price at or below 4x EBITDA.
Yes — speech therapy practices are SBA 7(a) eligible, making them accessible to buyers with as little as 10% equity injection. A buyer acquiring a $1.5M practice might contribute $150K–$200K in equity, finance $1.2M through an SBA 7(a) loan at 10-year terms, and negotiate a seller note of $75K–$150K with a 2-year standby period. The SBA's comfort with healthcare service businesses makes this one of the most capital-efficient paths to practice ownership available in the market.
Most de novo speech therapy practices require 18–36 months to reach consistent profitability. The primary bottlenecks are payer credentialing — which can take 3–6 months per insurer before you can bill insurance — and SLP hiring in a tight labor market. Founders who start with a telehealth component, private-pay model, or pre-existing school district contract can compress this timeline to 12–18 months, but count on needing 24 months of operating reserves before assuming stable EBITDA.
The most significant acquisition risk is clinician departure post-close. If the practice's licensed SLPs leave because of loyalty to the seller, compensation concerns, or cultural friction with new ownership, you may lose 30–60% of your billable revenue within the first 6–12 months. Mitigate this by conducting staff retention interviews during due diligence, structuring employment agreements and retention bonuses before close, and ensuring the seller commits to a genuine 12–24 month clinical transition — not just a handoff of patient charts.
Yes — a pre-existing referral relationship with a pediatric practice, school district, or hospital system is the single most valuable asset you can bring to a de novo launch. It solves the hardest problem in building from scratch: getting in front of patients before your runway runs out. If you have a physician or school administrator actively sending you families and have secured at least one major payer contract, the build path becomes viable and can generate equity value equal to or greater than an acquisition at a fraction of the upfront cost.
More Speech Therapy Practice Guides
Get access to acquisition targets with real revenue, real customers, and real cash flow.
Create your free accountNo credit card required
For Buyers
For Sellers